Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,324
Sort by:
2018 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
June 2018
820 pages
Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023
US$ 5,650.00
... in the market: Market Penetration: Comprehensive information on the top 15 players in the microbiology testing/clinical microbiology market. The report analyzes the microbiology testing market by application and region; and the clinical microbiology market by product ...
June 2018
224 pages
Hepatitis C: Drug Development Pipeline Study, H2 2018
US$ 1,500.00
... cirrhosis or liver cancer. Hepatitis C pipeline comprises of 85 active drugs under active development as of June 2018. Of these, 16 drugs are in Phase 1 and 19 drugs in phase 2. Only 4 drugs progressed to Phase 3. Further ...
June 2018
150 pages
Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
US$ 24,500.00
... Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, ... marketing tactics, and new products in R&D. Market Segmentation Analysis Comprehensive market segmentation analysis, including review of the market ... emerging clinical chemistry and immunodiagnostic tests. Review of current ...
June 2018
1115 pages
Zimmer: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Zimmer, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
Aesculap: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Aesculap, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
22 pages
Biomet: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Biomet, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Wright Medical: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
ConMed: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of ConMed, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Medtronic: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Medtronic, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Smith & Nephew: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
37 pages
Stryker: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Stryker, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Synthes: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Synthes, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
